Probiotic supplementation and associated infant gut microbiome and health: A cautionary retrospective clinical comparison

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Quin, C ^a   Estaki, M ^a   Vollman, D M ^a   Barnett, J A ^a   Gill, S K ^a   Gibson, D L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; VOLATILE FATTY ACID;

ADULT; BIFIDOBACTERIUM; BREAST FEEDING; BREAST MILK; DIETARY SUPPLEMENT; DRUG EFFECT; FECES; FEMALE; HUMAN; INFANT; INTESTINE FLORA; MALE; METABOLISM; MICROBIOLOGY; MICROFLORA; MOTHER; NEWBORN; PHYSIOLOGY; RETROSPECTIVE STUDY;

ADULT; BIFIDOBACTERIUM; BREAST FEEDING; DIETARY SUPPLEMENTS; FATTY ACIDS, VOLATILE; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INFANT; INFANT, NEWBORN; MALE; MICROBIOTA; MILK, HUMAN; MOTHERS; PROBIOTICS; RETROSPECTIVE STUDIES;

EID: 85047846294     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-26423-3     Document Type: Article

References (74)

1. Abrahamsson, T. R. et al. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy. 44(6), 842-850 (2014).
2. Frank, D. N. S. T. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America. 104(34), 13780-13785 (2007).
3. Ott, S. J. et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 53(5), 685-693 (2004).
4. Manichanh, C. et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by A metagenomic approach. Gut. 55(2), 205-211 (2006).
5. Wang, M. et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol. 121(1), 129-134 (2008).
6. Geuking, M. B., McCoy, K. D. & Macpherson, A. J. Metabolites from intestinal microbes shape Treg. Cell Res. 23(12), 1339-1340 (2013).
7. Ahern, P. P., Faith, J. J. & Gordon, J. I. Mining the human gut microbiota for effector strains that shape the immune system. Immunity. 40(6), 815-823 (2014).
8. Wu, W. et al. Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. Mucosal Immunol. 10(4), 946-956 (2017).
9. Ishikawa, T. & Nanjo, F. Dietary cycloinulooligosaccharides enhance intestinal immunoglobulin A production in mice. Biosci Biotechnol Biochem. 73(3), 677-682 (2009).
10. Renz, H., Brandtzaeg, P. & Hornef, M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nature reviews. Immunology. 12(1), 9-23 (2011).
11. FAO/WHO. Guidelines for evaluating probiotics in food. Report of A joint FAO/WHO working group on drafting guidelines for the evaluations of probiotics in food; Ontario, Canada. (2002).
12. D. O. H. Government of the District of Columbia, Department of Health. Fatal Gastrointestinal Mucormycosis in an Infant Following Ingestion of Conaminated Dietary Supplement; https://doh. dc. gov/release/fatal-gastrointestinal-mucormycosis-infant-followingingestion-contaminated-dietary (2014).
13. Zuccotti, G. et al. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy. 70(11), 1356-1371 (2015).
14. Topcuoglu, S., Gursoy, T., Ovali, F., Serce, O. & Karatekin, G. A new risk factor for neonatal vancomycin-resistant Enterococcus colonisation: bacterial probiotics. J Matern Fetal Neonatal Med. 28(12), 1491-1494 (2015).
15. Abe, A. M., Gregory, P. J., Hein, D. J., Cochrane, Z. R. & Wilson, A. F. Survey and Systematic Literature Review of Probiotics Stocked in Academic Medical Centers within the United States. Hosp Pharm. 48(10), 834-847 (2013).
16. Williams, M. D., Ha, C. Y. & Ciorba, M. A. Probiotics as therapy in gastroenterology: A study of physician opinions and recommendations. J Clin Gastroenterol. 44(9), 631-636 (2010).
17. Hickey, Y. & Corish, C. Irish dietitians' opinions and use of probiotics in patients with Clostridium difficile-associated disease. J Clin Gastroenterol. 45(6), 568-569 (2011).
18. Hammerman, C., Bin-Nun, A. & Kaplan, M. Safety of probiotics: comparison of two popular strains. BMJ. 333(7576), 1006-1008 (2006).
19. Reuter, G. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol. 2(2), 43-53 (2001).
20. Gasbarrini, G., Bonvicini, F., Gramenzi, A. Probiotics History. J Clin Gastroenterol. Nov/Dec 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, S116-S119 (2015).
21. Lozupone, C. & Knight, R. UniFrac: A new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 71(12), 8228-8235 (2005).
22. Mandal, S. et al. Analysis of composition of microbiomes: A novel method for studying microbial composition. Microb Ecol Health Dis. 26, 27663 (2015).
23. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome biology. 12(6), R60 (2011).
24. Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 31(9), 814-821 (2013).
25. Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 341(6145), 569-573 (2013).
26. Turfkruyer, M. & Verhasselt, V. Breast milk and its impact on maturation of the neonatal immune system. Current opinion in infectious diseases. 28(3), 199-206 (2015).
27. Newburg, D. S. & Walker, W. A. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res. 61(1), 2-8 (2007).
28. Bron, P. A., van Baarlen, P. & Kleerebezem, M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol. 10(1), 66-78 (2011).
29. Jain, N. & Walker, W. A. Diet and host-microbial crosstalk in postnatal intestinal immune homeostasis. Nature reviews. Gastroenterology & hepatology. 12(1), 14-25 (2015).
30. Goldsmith, F., O'Sullivan, A., Smilowitz, J. T. & Freeman, S. L. Lactation and Intestinal Microbiota: How Early Diet Shapes the Infant Gut. J Mammary Gland Biol Neoplasia. 20(3-4), 149-158 (2015).
31. Martin, R. et al. Cultivation-independent assessment of the bacterial diversity of breast milk among healthy women. Res Microbiol. 158(1), 31-37 (2007).
32. Donnet-Hughes, A. et al. Potential role of the intestinal microbiota of the mother in neonatal immune education. Proc Nutr Soc. 69(3), 407-415 (2010).
33. Scholtens, P. A., Oozeer, R., Martin, R., Amor, K. B. & Knol, J. The early settlers: intestinal microbiology in early life. Annu Rev Food Sci Technol. 3, 425-447 (2012).
34. Dotterud, C. K. et al. Does Maternal Perinatal Probiotic Supplementation Alter the Intestinal Microbiota of Mother and Child? J Pediatr Gastroenterol Nutr. 61(2), 200-207 (2015).
35. Round, J. L. & Mazmanian, S. K. The gut microbiota shapes intestinal immune responses during health and disease. Nature reviews. Immunology. 9(5), 313-323 (2009).
36. Gibson, G. R. & Wang, X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol. 77(4), 412-420 (1994).
37. Ouwehand, A., Isolauri, E. & Salminen, S. The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr. 41(Suppl 1), I32-37 (2002).
38. Baldassarre, M. E. et al. Administration of A Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial. Nutrients. 8(11) (2016).
39. Cash, H. L., Whitham, C. V., Behrendt, C. L. & Hooper, L. V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 313(5790), 1126-1130 (2006).
40. Sonnenburg, J. L., Chen, C. T. & Gordon, J. I. Genomic and metabolic studies of the impact of probiotics on A model gut symbiont and host. PLoS Biol. 4(12), e413 (2006).
41. Panigrahi, P. et al. A randomized synbiotic trial to prevent sepsis among infants in rural India. Nature. 548(7668), 407-412 (2017).
42. Panigrahi, P. et al. Long-term colonization of A Lactobacillus plantarum synbiotic preparation in the neonatal gut. J Pediatr Gastroenterol Nutr. 47(1), 45-53 (2008).
43. Janda, J. M. & Abbott, S. L. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol. 45(9), 2761-2764 (2007).
44. Awad, A. & Al-Shaye, D. Public awareness, patterns of use and attitudes toward natural health products in Kuwait: A cross-sectional survey. BMC Complement Altern Med. 14, 105 (2014).
45. Health Canada. Natural Health Product Tracking Survey-2010 Final Report. 2010.
46. Arthur, J. C. et al. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep. 3, 2868 (2013).
47. Besselink, M. G. et al. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet. 371(9613), 651-659 (2008).
48. Kennedy, J., Wang, C. C. & Wu, C. H. Patient Disclosure about Herb and Supplement Use among Adults in the US. Evid Based Complement Alternat Med. 5(4), 451-456 (2008).
49. Kemper, K. J. & O'Connor, K. G. Pediatricians' recommendations for complementary and alternative medical (CAM) therapies. Ambul Pediatr. 4(6), 482-487 (2004).
50. Sawni, A. & Thomas, R. Pediatricians' attitudes, experience and referral patterns regarding Complementary/Alternative Medicine: A national survey. BMC Complement Altern Med. 7, 18 (2007).
51. Government of Canada. ARCHIVED-Charting A Course: Refining Canada's Approach to Regulating Natural Health Products (2010).
52. Faul, F., Erdfelder, E., Lang, A. G. & Buchner, A. GPower 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior research methods. 39(2), 175-191 (2007).
53. Faul, F., Erdfelder, E., Buchner, A. & Lang, A. G. Statistical power analyses using GPower 3. 1: tests for correlation and regression analyses. Behavior research methods. 41(4), 1149-1160 (2009).
54. Azad, M. B. et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ. 185(5), 385-394 (2013).
55. STROBE. STROBE Statement, strengthening the reporting of observational studies in epidemiology. STROBE Statement, strengthening the reporting of observational studies in epidemiology; https://www. strobe-statement. org/index. php?id=availablechecklists (2009).
56. Ramage, S. M., McCargar, L. J., Berglund, C., Harber, V. & Bell, R. C. Assessment of Pre-Pregnancy Dietary Intake with A Food Frequency Questionnaire in Alberta Women. Nutrients. 7(8), 6155-6166 (2015).
57. Ramakrishnan, R., Venkatarao, T., Koya, P. K. & Kamaraj, P. Influence of recall period on estimates of diarrhoea morbidity in infants in rural Tamilnadu. Indian J Public Health. 43(4), 136-139 (1999).
58. Martorell, R., Habicht, J. P., Yarbrough, C., Lechtig, A. & Klein, R. E. Underreporting in fortnightly recall morbidity surveys. J Trop Pediatr Environ Child Health. 22(3), 129-134 (1976).
59. Imhoff-Kunsch, B. et al. Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial. Pediatrics. 128(3), e505-512 (2011).
60. Gorzelak, M. A. et al. Methods for Improving Human Gut Microbiome Data by Reducing Variability through Sample Processing and Storage of Stool. PLoS One. 10(8), e0134802 (2015).
61. Klindworth, A. et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencingbased diversity studies. Nucleic acids research. 41(1), e1 (2013).
62. Nextera. Nextera XT Sample Preparation Guide (2012).
63. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods. 7(5), 335-336 (2010).
64. Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nature methods. 13(7), 581-583 (2016).
65. Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 30(4), 772-780 (2013).
66. Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2-approximately maximum-likelihood trees for large alignments. PloS one. 5(3), e9490 (2010).
67. Rognes, T., Flouri, T., Nichols, B., Quince, C. & Mahe, F. VSEARCH: A versatile open source tool for metagenomics. PeerJ. 4, e2584 (2016).
68. Parks, D. H., Tyson, G. W., Hugenholtz, P. & Beiko, R. G. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 30(21), 3123-3124 (2014).
69. Estaki, M. et al. Cardiorespiratory fitness as A predictor of intestinal microbial diversity and distinct metagenomic functions. Microbiome. 4(1), 42 (2016).
70. Brown, K. et al. Prolonged antibiotic treatment induces A diabetogenic intestinal microbiome that accelerates diabetes in NOD mice. The ISME journal. (2015).
71. Wang, Y. N. U., Wright, S. T. & Warton, D. I. mvabund-an R package for model-based analysis of multivariate abundance data. methods in Ecology and Evolution. 3(3), 471-474 (2012).
72. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria (2014).
73. Burnham, K. P., Anderson, D. R. Model Selection and Multimodel Inference. In: Springer, ed. Model Selection and Multimodel Inference. A PracticalInformation-Theoretic Approach. seconded (2002).
74. Bartoñ, K. MuMIn: multi-model inference (R package version 0. 40. 4)., http://r-forge. r-project. org/projects/mumin/(2009).